These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32923608)

  • 21. Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in γδT cells.
    Suh JH; Lee Y; Ohn J; Kim EJ; Kim TG; Jo SJ; Kim SJ; Chung JH
    J Dermatol Sci; 2022 Apr; 106(1):45-52. PubMed ID: 35331618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques.
    Marepally S; Boakye CH; Patel AR; Godugu C; Doddapaneni R; Desai PR; Singh M
    Nanomedicine (Lond); 2014 Jul; 9(14):2157-74. PubMed ID: 24593003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61.
    Guo WJ; Wang Y; Deng Y; Cheng LY; Liu X; Xi RF; Zhu SJ; Feng XY; Hua L; Ze K; Zhu JY; Guo DJ; Li FL
    J Integr Med; 2022 Jul; 20(4):376-384. PubMed ID: 35491357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
    Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
    Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimeric translationally controlled tumor protein-binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells.
    Cho H; Je JH; Kang J; Jeong MG; Song J; Jeon Y; Lee K; Hwang ES
    Biomed Pharmacother; 2022 Aug; 152():113245. PubMed ID: 35689858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
    Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
    J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis.
    Choudhary V; Kaddour-Djebbar I; Custer VE; Uaratanawong R; Chen X; Cohen E; Yang R; Ajebo E; Hossack S; Bollag WB
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis.
    Sakurai K; Dainichi T; Garcet S; Tsuchiya S; Yamamoto Y; Kitoh A; Honda T; Nomura T; Egawa G; Otsuka A; Nakajima S; Matsumoto R; Nakano Y; Otsuka M; Iwakura Y; Grinberg-Bleyer Y; Ghosh S; Sugimoto Y; Guttman-Yassky E; Krueger JG; Kabashima K
    J Allergy Clin Immunol; 2019 Oct; 144(4):1036-1049. PubMed ID: 31378305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation.
    Pan Y; You Y; Sun L; Sui Q; Liu L; Yuan H; Chen C; Liu J; Wen X; Dai L; Sun H
    Br J Pharmacol; 2021 Dec; 178(24):4907-4922. PubMed ID: 34460100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polydopamine/IR820 nanoparticles as topical phototheranostics for inhibiting psoriasiform lesions through dual photothermal and photodynamic treatments.
    Nirmal GR; Lin ZC; Lin CH; Sung CT; Liao CC; Fang JY
    Biomater Sci; 2022 Oct; 10(21):6172-6189. PubMed ID: 36073349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protein corona modulates the inflammation inhibition by cationic nanoparticles
    Liu X; Liang H; Yan Y; Wu J; Bottini M; Liu L; Chen Y
    Bioact Mater; 2022 Jul; 13():249-259. PubMed ID: 35224306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis.
    Li L; Wu Z; Wu M; Qiu X; Wu Y; Kuang Z; Wang L; Sun T; Liu Y; Yi S; Jing H; Zhou S; Chen B; Wu D; Wu W; Liu J
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107008. PubMed ID: 33069927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palbociclib blocks neutrophilic phosphatidylinositol 3-kinase activity to alleviate psoriasiform dermatitis.
    Chen PJ; Tseng HH; Wang YH; Fang SY; Chen SH; Chen CH; Tsai SC; Chang YC; Tsai YF; Hwang TL
    Br J Pharmacol; 2023 Aug; 180(16):2172-2188. PubMed ID: 36967633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcutaneous delivery of mung bean-derived nanoparticles for amelioration of psoriasis-like skin inflammation.
    Sun H; Zhao Y; Zhang P; Zhai S; Li W; Cui J
    Nanoscale; 2022 Feb; 14(8):3040-3048. PubMed ID: 35142774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.
    Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y
    Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils
    Lin CY; Yu HP; Chang YT; Lin ZC; Alalaiwe A; Hwang TL; Fang JY
    Biomater Sci; 2023 Jan; 11(3):873-893. PubMed ID: 36515218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
    Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
    Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
    Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
    Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
    Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
    J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.